SynAct Pharma AB · OMXSTO:SYNACT

TJ Biotech Holding ApS bought 3,529 SynAct Pharma AB shares (MAR article 19 notification)

Traded Dec 19, 2025 · Filed Dec 31, 2025 · Read by 6ix Oct 14, 2026

On Dec 19, 2025, TJ Biotech Holding ApS (Closely associated with Thomas Jonassen (Other senior executive)) bought 3,529 SynAct Pharma AB shares at SEK 20.45 for SEK 72,168. Filed Dec 31, 2025 (MAR article 19 notification).

Bought
3,529 shares
Price
SEK 20.45
Value
SEK 72,168
Role
Closely associated with Thomas Jonassen (Other senior executive)

The register entry

DateSecurityTransactionSharesPriceHolding afterOwnership
Dec 19, 2025SynAct Pharma ABBuy3,529SEK 20.45Indirect

Source

View original at Finansinspektionen

Related